The table below shows COLLEGIUM PHARMACEUTICAL, INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Revenue
$193.52M
$205.45M
$209.36M
$188.00M
$177.76M
$181.95M
Cost of revenue
$76.27M
$77.07M
$80.19M
$79.62M
$80.43M
$83.66M
Gross profit
$117.25M
$128.38M
$129.17M
$108.38M
$97.32M
$98.29M
R&D
-
-
-
-
-
-
COLL annual revenue (10-K history)
COLLEGIUM PHARMACEUTICAL, INC reported annual revenue of $780.57M for fiscal year 2025. That is up 23.6% from $631.45M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.71M (FY 2016) to $780.57M. Figures come from the company's audited annual reports as filed with the SEC.